Figure 4.
Comparison of prophylactic treatment with the different FIX agents in CRM+ mice. (A) SVBA 7 days after the infusion of 150 IU/kg FIXWT, FIXFC, or FIXAlb in CRM+ mice. Results for untreated CRM+ and wild-type mice are also shown. (B) SVBA 7 days after the infusion of extremely high doses of FIXWT, FIXFC, and FIXAlb in CRM+ mice. Untreated CRM+ mice (orange), FIXWT (green), FIXFC (purple), FIXAlb (blue), WT mice (red). Box plot rendition of the results showing the minimum, first quartile, median (waist), third quartile, and maximum values. Note no difference between agents at the 150 IU/kg dose, but significantly increased efficacy with FIXFC at very high doses.

Comparison of prophylactic treatment with the different FIX agents in CRM+ mice. (A) SVBA 7 days after the infusion of 150 IU/kg FIXWT, FIXFC, or FIXAlb in CRM+ mice. Results for untreated CRM+ and wild-type mice are also shown. (B) SVBA 7 days after the infusion of extremely high doses of FIXWT, FIXFC, and FIXAlb in CRM+ mice. Untreated CRM+ mice (orange), FIXWT (green), FIXFC (purple), FIXAlb (blue), WT mice (red). Box plot rendition of the results showing the minimum, first quartile, median (waist), third quartile, and maximum values. Note no difference between agents at the 150 IU/kg dose, but significantly increased efficacy with FIXFC at very high doses.

Close Modal

or Create an Account

Close Modal
Close Modal